We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $97M
1-Year Est. Return 57.2%
This Fund
S&P 500
This Quarter Est. Return
-13.39%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
AUM
$6.46M
AUM Growth
-$930K
Cap. Flow
+$575K
Cap. Flow %
8.9%
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
Reduced
Closed
1

Top Sells

1
CRVO icon
CervoMed
CRVO
+$22K

Sector Composition

1 Financials 75.99%
2 Healthcare 22.44%
3 Consumer Staples 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABGI
1
DELISTED
ABG Acquisition Corp. I
ABGI
$4.91M 75.99%
501,300
SONX
2
DELISTED
Sonendo, Inc.
SONX
$942K 14.57%
547,945
CSTL icon
3
Castle Biosciences
CSTL
$733M
$452K 6.99%
+20,592
New +$478K
PRE icon
4
Prenetics Global
PRE
$311M
$101K 1.56%
+1,667
New +$119K
SYRE icon
5
Spyre Therapeutics
SYRE
$8.7B
$57K 0.88%
4,482
CRVO icon
6
CervoMed
CRVO
$28.5M
-1,198
Closed -$22K

Similar funds

Yu Fan's Q2 2022 Portfolio in Review

As of Q2 2022, Yu Fan held 6 positions worth $6.46M, down 13% from $7.39M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Yu Fan deployed $575K of net new capital in Q2 2022, opening 2 new positions. Its largest new stake was Castle Biosciences: 20,592 shares worth $452K.

By sector, the portfolio is most concentrated in Financials at 76% of assets, up from 67% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the most notable exit was CervoMed, an estimated $22K sold.

  • Yu Fan's largest Q2 2022 buy was Castle Biosciences: 20,592 shares worth $452K.
  • Yu Fan fully exited CervoMed in Q2 2022, selling an estimated $22K.
  • Yu Fan's ten largest holdings make up 100% of its $6.46M portfolio in Q2 2022.
  • Yu Fan opened 2 new positions and closed 1 in Q2 2022.
  • Yu Fan's portfolio value fell 13% quarter-over-quarter to $6.46M.

Based on Yu Fan's 13F filing for Q2 2022, filed 15 Aug 2022.